US Patent Issued to SK BIOSCIENCE on May 20 for "Recombinant RSV live vaccine strain and the preparing method thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,929, issued on May 20, was assigned to SK BIOSCIENCE Co. LTD. (Seongnam-si, South Korea).

"Recombinant RSV live vaccine strain and the preparing method thereof" was invented by Ki-weon Seo (Seongnam-si, South Korea), Eun-som Kim (Seongnam-si, South Korea) and Teawoo Kwon (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a recombinant attenuated respiratory syncytial virus (RSV) comprising F protein of stabilized pre-fusion RSV, or comprising protein consisting of the amino acid sequence represented by SEQ ID NO: 2 or functional fragment thereof, and provides genome of the recombinant RSV and a re...